P3.01-81 Long-Term Outcome of Surgically Resected Unsuspected N2 Lung Adenocarcinoma

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.16-43 Analyses of Long-Term Outcomes and Prognostic Factors in Surgically Resected ALK-Rearranged Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Prognostic Significance of IMMT Expression in Surgically‐resected Lung Adenocarcinoma

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

P3.01-31 Prognostic Factors in Patients With Resected Pathological N2 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Uncommon Features of Surgically Resected ALK-positive Cavitary Lung Adenocarcinoma: A Case Report

Surgical Case Reports
2017English

P1.16-31 Surgically Resected Acinar Adenocarcinoma of the Lung: Analysis of Different Prognostic Groups

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.16-03 Uncommon EGFR Mutations as a Worse Prognostic Factor for Surgically Resected Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Long Term Outcome of Ruptured Vertebrobasilar Artery Dissection Treated Non-Surgically

Surgery for Cerebral Stroke
2010English

Prognostic Significance of XB130 Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma

World Journal of Surgical Oncology
SurgeryOncology
2014English

Protein Expression of Programmed Death 1 Ligand 1 and Ligand 2 Independently Predict Poor Prognosis in Surgically Resected Lung Adenocarcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy